BACKGROUND: Vitamin D plays a role in cancer tumorogenesis and acts through the vitamin D receptor (VDR). Although African Americans have the lowest serum vitamin D levels, supplementation has not yielded a significant improvement in cancer. Gene polymorphisms in VDR may play a role. There is a dearth of information on VDR gene polymorphisms and colorectal cancer (CRC) among under-represented ethnic groups. In this study, the authors examined whether VDR gene single nucleotide polymorphisms (SNPs) were associated with CRC in predominately African American and Hispanic study participants. METHODS: Blood samples were collected from 378 participants, including a group of 78 patients with CRC (cases), a group of 230 noncancer participants without polyps (controls without polyps), and a group of 70 noncancer participants with polyps (controls with polyps). The 4 polymorphic SNPs in VDR (FokI, BsmI, TaqI, and ApaI) were assessed using the polymerase chain reaction-restriction fragment length polymorphism method. RESULTS: There was a significant association of the VDR-FokI FF genotype with CRC cases (odds ratio, 2.9; P= .036) compared with the controls without polyps. The most common VDR-FokI genotype in the overall study population was the FF genotype (46%). However, upon breakdown by ethnicity, the FF genotype was the most common in African American participants (61%), and the Ff genotype was the most common in Hispanic/Latino participants (49%). When the association was assessed in a multivariate model, there was no significant association with any VDR polymorphism and CRC cases (P> .05). The other 3 polymorphic variants of VDR (BsmI, TaqI, and ApaI) were not associated with CRC. CONCLUSIONS: The results from this study suggest that genetic variation of the VDR-FokI SNPs may influence CRC risk, particularly in African American cohorts.
BACKGROUND:Vitamin D plays a role in cancer tumorogenesis and acts through the vitamin D receptor (VDR). Although African Americans have the lowest serum vitamin D levels, supplementation has not yielded a significant improvement in cancer. Gene polymorphisms in VDR may play a role. There is a dearth of information on VDR gene polymorphisms and colorectal cancer (CRC) among under-represented ethnic groups. In this study, the authors examined whether VDR gene single nucleotide polymorphisms (SNPs) were associated with CRC in predominately African American and Hispanic study participants. METHODS: Blood samples were collected from 378 participants, including a group of 78 patients with CRC (cases), a group of 230 noncancer participants without polyps (controls without polyps), and a group of 70 noncancer participants with polyps (controls with polyps). The 4 polymorphic SNPs in VDR (FokI, BsmI, TaqI, and ApaI) were assessed using the polymerase chain reaction-restriction fragment length polymorphism method. RESULTS: There was a significant association of the VDR-FokI FF genotype with CRC cases (odds ratio, 2.9; P= .036) compared with the controls without polyps. The most common VDR-FokI genotype in the overall study population was the FF genotype (46%). However, upon breakdown by ethnicity, the FF genotype was the most common in African American participants (61%), and the Ff genotype was the most common in Hispanic/Latino participants (49%). When the association was assessed in a multivariate model, there was no significant association with any VDR polymorphism and CRC cases (P> .05). The other 3 polymorphic variants of VDR (BsmI, TaqI, and ApaI) were not associated with CRC. CONCLUSIONS: The results from this study suggest that genetic variation of the VDR-FokI SNPs may influence CRC risk, particularly in African American cohorts.
Authors: Thomas U Ahearn; Marjorie L McCullough; W Dana Flanders; Qi Long; Eduard Sidelnikov; Veronika Fedirko; Carrie R Daniel; Robin E Rutherford; Aasma Shaukat; Roberd M Bostick Journal: Cancer Res Date: 2010-11-17 Impact factor: 12.701
Authors: Martha L Slattery; Maureen Murtaugh; Bette Caan; Khe Ni Ma; Roger Wolff; Wade Samowitz Journal: Cancer Causes Control Date: 2004-11 Impact factor: 2.506
Authors: Heather M Ochs-Balcom; Mine S Cicek; Cheryl L Thompson; Thomas C Tucker; Robert C Elston; Sarah J Plummer; Graham Casey; Li Li Journal: Carcinogenesis Date: 2008-07-14 Impact factor: 4.944
Authors: Veronika Fedirko; Roberd M Bostick; W Dana Flanders; Qi Long; Aasma Shaukat; Robin E Rutherford; Carrie R Daniel; Vaunita Cohen; Chiranjeev Dash Journal: Cancer Prev Res (Phila) Date: 2009-03-03
Authors: Britton Trabert; Kathleen E Malone; Janet R Daling; David R Doody; Leslie Bernstein; Giske Ursin; Polly A Marchbanks; Brian L Strom; Mariela C Humphrey; Elaine A Ostrander Journal: Breast Cancer Res Date: 2007 Impact factor: 6.466
Authors: S Vladoiu; A Botezatu; G Anton; D Manda; D L Paun; S Oros; R Rosca; D Dinu Draganescu Journal: Acta Endocrinol (Buchar) Date: 2017 Jul-Sep Impact factor: 0.877
Authors: Khayal A Alkhayal; Zainab H Awadalia; Mansoor-Ali Vaali-Mohammed; Omar A Al Obeed; Alanoud Al Wesaimer; Rabih Halwani; Ahmed M Zubaidi; Zahid Khan; Maha-Hamadien Abdulla Journal: PLoS One Date: 2016-06-16 Impact factor: 3.240
Authors: Yun Zhu; Peizhong Peter Wang; Guangju Zhai; Bharati Bapat; Sevtap Savas; Jennifer R Woodrow; Ishor Sharma; Yuming Li; Xin Zhou; Ning Yang; Peter T Campbell; Elizabeth Dicks; Patrick S Parfrey; John R Mclaughlin Journal: Br J Cancer Date: 2017-08-01 Impact factor: 7.640